Osteoporosis, a Disease With Few Treatment Options, May Soon Have One More - New York Times

New York TimesOsteoporosis, a Disease With Few Treatment Options, May Soon Have One MoreNew York TimesThe clinical trial of the new drug was conducted by Radius, and the results were published on Tuesday in The Journal of the American Medical Association. The trial compared the new drug, abaloparatide, with a placebo and with Lilly's drug, Forteo.